Антропометрические индексы ожирения и кардиометаболический риск: есть ли связь?

Жировая ткань в настоящее время рассматривается в качестве ключевого органа в отношении избыточного количества пищевых липидов, которые определяют, будет ли организм поддерживать нормальный гомеостаз или будут возникать состояния воспаления, инсулинорезистентности. В последние годы в литературе возросло количество информации об относительно новых прогностических моделях — индексе висцерального ожирения и индексе накопления липидов. Цель обзора — критический анализ результатов исследований по изучению взаимосвязи различных индексов ожирения и кардиометаболического риска. Проанализированы 105 источников литературы, из них 53 источника исключены, т.к. интересующие процессы не были подробно описаны или включали оценку взаимосвязей различных индексов ожирения с метаболическими параметрами. Полученные результаты свидетельствуют о целесообразности использования новых индексов ожирения, которые обладают хорошей предиктивной способностью, и достаточно просты и удобны в применении. Необходимо использовать дополнительные методы антропометрического и клинического обследования с целью оценки метаболического фенотипа ожирения, что позволит стратифицировать пациентов по уровню кардиометаболического риска для последующего формирования комплекса профилактических мероприятий, направленных на улучшение диагностики и стратегии лечения.

1. Ndumele CE, Matsushita K, Lazo M, et al. Obesity and subtypes of incident cardiovascular disease. J Am Heart Assoc. 2016;5:334-9. https://doi.org/10.1161/JAHA.116.003921.

2. Козупеева Д. А., Мустафина С. В. Метаболически здоровое ожирение и атеросклероз-ассоциированные заболевания. Атеросклероз. 2016;12(2):42-7.

3. Rossi R, Iaccarino D, Nuzzo A, et al. Influence of body mass index on extent of coronary atherosclerosis and cardiac events in a cohort of patients at risk of coronary artery disease. Nutr Metab Cardiovasc Dis. 2011;21(2):86-93. https://doi.org/10.1016/j.numecd.2009.09.001.

4. Барбараш О. Л., Воевода М. И., Галстян Г. Р. и др. Предиабет как междисциплинарная проблема: определение, риски, подходы к диагностике и профилактике сахарного диабета 2 типа и сердечно-сосудистых осложнений. Российский кардиологический журнал. 2019;(4):83-91. https://doi.org/10.15829/1560-4071-2019-4-83-91.

5. Сваровская А. В., Тепляков А. Т. Инсулинорезистентность при сахарном диабете. Контроль над риском кардиоваскулярных осложнений. Томск: НИИ кардиологии, Томский НИМЦ, 2018. 196 с. ISBN: 978-5-6040497-6-1.

6. Roriz C, Karla A, Passos S, et al. Anthropometric clinical indicators in the assessment of visceral obesity: an update. Nutr Clín Diet Hosp. 2016;36(2):168-79. https://doi.org/10.12873/362carneirororiz.

7. Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension. 2001;37(5):1199-208. https://doi.org/10.1161/01.HYP.37.5.1199.

8. Poirier P, Cornier MA, Mazzone T, et al. Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association. Circulation. 2011;123(15):1683-701. https://doi.org/10.1161/CIR.0b013e3182149099.

9. The Global BMI Mortality Collaboration. Body-mass index and all-cause mortality: individual participant-data metaanalysis of 239 prospective studies in four continents. Lancet. 2016;388(10046):776-86. https://doi.org/10.1016/S0140-6736(16)30175-1.

10. Hamer M, Stamatakis E. Overweight and obese cardiac patients have better prognosis despite reporting worse perceived health and more conventional risk factors. Prev Med. 2013;57(1):12-6. https://doi.org/10.1016/j.ypmed.2013.02.012.

11. Wormser D, Kaptoge S, Di AE, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet. 2011;377(9771):1085-95. https://doi.org/10.1016/S0140-6736(11)60105-0.

12. Heymsfield SB, Peterson CM, Thomas DM, et al. Why are there race/ethnic differences in adult body mass indexadiposity relationships? A quantitative critical review. Obes Rev. 2016;17(3):262-75. https://doi.org/10.1111/obr.12358.

13. Nazare JA, Smith JD, Borel AL, et al. Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: The international study of prediction of intra-abdominal adiposity and its relationship with cardiometabolic risk/intra-abdominal adiposity. Am J Clin Nutr. 2012;96(4):714-26. https://doi.org/10.3945/ajcn.112.035758.

14. Haldar S, Chia SC, Henry CJ. Body composition in Asians and Caucasians: comparative analyses and influences on cardiometabolic outcomes. Adv Food Nutr Res. 2015;75:97-154. https://doi.org/10.1016/bs.afnr.2015.07.001.

15. Беленькая Л. В. Критерии ожирения в азиатской популяции. Обзор литературы. Acta biomedica scientifica. 2018;3(3):99-102. https://doi.org/10.29413/ABS.2018-3.3.15.

16. Tutunchi H, Ostadrahimi A, Hosseinzadeh-Attar M-J, et al. A systematic review of the association of neuregulin 4, a brown fat-enriched secreted factor, with obesity and related metabolic disturbances. Obes Rev. 2020;21:e12952. https://doi.org/10.1111/obr.12952.

17. Дружилов М. А., Дружилова О. Ю., Кузнецова Т. Ю. и др. Ожирение как фактор сердечно-сосудистого риска: акцент на качество и функциональную активность жировой ткани. Российский кардиологический журнал. 2015;(4):111-117. https://doi.org/10.15829/1560-4071-2015-4-111-117.

18. Ahmad N, Adam SI, Nawi AM, et al. Abdominal obesity indicators: waist circumference or waist-to-hip ratio in Malaysian adults population. Int J Prev Med. 2016;7:82. https://doi.org/10.4103/2008-7802.183654.

19. Borel A-L, Coumes S, Reche F, et al. Waist, neck circumferences, waist-to-hip ratio: Which is the best cardiometabolic risk marker in women with severe obesity? The SOON cohort. PLoS One. 2018;13(11):e0206617. https://doi.org/10.1371/journal.pone.0206617.

20. Despres JP. Excess visceral adipose tissue/ectopic fat the missing link in the obesity paradox? J Am Coll Cardiol. 2011;57:1887-9. https://doi.org/10.1016/j.jacc.2010.10.063.

21. Tran NTT, Blizzard CL, Luong KN, et al. The importance of waist circumference and body mass index in cross-sectional relationships with risk of cardiovascular disease in Vietnam. PLoS One. 2018;13(5):e0198202. https://doi.org/10.1371/journal.pone.0198202.

22. Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and metaanalysis. Obes Rev. 2012;13(3):275-86. https://doi.org/10.1111/j.1467-789X.2011.00952.x.

23. Yoo EG. Waist-to-height ratio as a screening tool for obesity and cardiometabolic risk. Korean J Pediatr. 2016;59(11):425-31. https://doi.org/10.3345/kjp.2016.59.11.425.

24. Eloi JC, Epifanio M, de Gonçalves MM, et al. Quantification of abdominal fat in obese and healthy adolescents using 3 tesla magnetic resonance imaging and free software for image analysis. PLoS One. 2017;12(1):e0167625. https://doi.org/10.1371/journal.pone.0167625.

25. Wolfgram PM, Connor EL, Rehm JL, et al. In Nonobese Girls, Waist Circumference as a Predictor of Insulin Resistance Is Comparable to MRI Fat Measures and Superior to BMI. Horm Res Paediatr. 2015;84(4):258-65. https://doi.org/10.1159/000439130.

26. David CN, Mello RB, Bruscato NM, et al. Overweight and Abdominal Obesity Association with All-Cause and Cardiovascular Mortality in the Elderly Aged 80 and Over: A Cohort Study. J Nutr Health Aging. 2017;21(5):597-603. https://doi.org/10.1007/s12603-016-0812-0.

27. Nurdiantami Y, Watanabe K, Tanaka E, et al. Association of general and central obesity with hypertension. Clin Nutr. 2018;37(4):1259-63. https://doi.org/10.1016/j.clnu.2017.05.012.

28. Ashtary-Larky D, Daneghian S, Alipour M, et al. Waist circumference to height ratio: better correlation with fat mass than other anthropometric indices during dietary weight loss in different rates. Int J Endocrinol Metab. 2018;16(4):e55023. https://doi.org/10.5812/ijem.55023.

29. Savva SC, Lamnisos D, Kafatos A. Predicting cardiometabolic risk: waist-to-height ratio or BMI. A meta-analysis. Diabetes Metab Syndr Obes. 2013;6:403-19. https://doi.org/10.2147/DMSO.S34220.

30. Tutunchi H, Ebrahimi Mameghani M, Ostadrahimi A, et al. What are the optimal cut-off points of anthropometric indicesfor prediction of overweight and obesity? Predictive validity of waist circumference, waist-to-hip and waist-to-height ratios. Health Promot Perspect. 2020;10(2):142-7. https://doi.org/10.34172/hpp.2020.23.

31. Amato MC, Giordano C, Pitrone M, et al. Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population. Lipids Health Dis. 2011;10:183. https://doi.org/10.1186/1476-511X-10-183.

32. Pekgor S, Duran C, Berberoglu U, et al. The role of visceral adiposity index levels in predicting the presence of metabolic syndrome and insulin resistance in overweight and obese patients. Metab Syndr Relat Disord. 2019;17:296-302. https://doi.org/10.1089/met.2019.0005.

33. Amato MC, Pizzolanti G, Torregrossa V, et al. Visceral adiposity index (VAI) is predictive of an altered adipokine profile in patients with type 2 diabetes. PLoS One. 2014;9:e91969. https://doi.org/10.1371/journal.pone.0091969.

34. Liu PJ, Ma F, Lou HP, et al. Visceral adiposity index is associated with pre-diabetes and type 2 diabetes mellitus in Chinese adults aged 20-50. Ann. Nutr. Metab. 2016;68:235-43. https://doi.org/10.1159/000446121.

35. Jabłonowska-Lietz B, Wrzosek M, Włodarczyk M, et al. New indexes of body fat distribution, visceral adiposity index, body adiposity index, waist-to-height ratio, and metabolic disturbances in the obese. Kardiol Pol. 2017;75:1185-91. https://doi.org/10.5603/KP.a2017.0149.

36. Li R, Li Q, Cui M, et al. Visceral adiposity index, lipid accumulation product and intracranial atherosclerotic stenosis in middle-aged and elderly Chinese. Sci Rep. 2017;7:7951. https://doi.org/10.1038/s41598-017-07811-7.

37. Randrianarisoa E, Lehn-Stefan A, Hieronimus A, et al. Visceral adiposity index as an independent marker of subclinical atherosclerosis in individuals prone to diabetes mellitus. J Atheroscler Thromb. 2019;26(9):821-34. https://doi.org/10.5551/jat.47274.

38. Biswas E, Choudhury AK, Amin MR, et al. Visceral adiposityindex score is the better predictor of clinical and coronary angiographic severity assessment than other adiposity indices in patients with acute coronary syndrome. Mymensingh Med J. 2019;28:382-8.

39. Mazidi M, Kengne A-Pascal, Katsiki N, et al. Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance. J Diabetes Complicat. 2018;32:266-70. https://doi.org/10.1016/j.jdiacomp.2017.10.007.

40. Oh JY, Sung YA, Lee H. The lipid accumulation product as a useful index for identifying abnormal glucose regulation in young Korean women. Diabet Med. 2013;30(4):436-42. https://doi.org/10.1111/dme.12052.

41. Abruzzese GA, Cerrrone GE, Gamez JM, et al. Lipid accumulation product (LAP) and visceral adiposity index (VAI) as markers of insulin resistance and metabolic associated disturbances in young argentine women with polycystic ovary syndrome. Horm Metab Res. 2017;49(01):23-9. https://doi.org/10.1055/s-0042-113463.

42. Wakabayashi I, Daimon T. A strong association between lipid accumulation product and diabetes mellitus in Japanese women and men. J Atheroscler Thromb. 2014;21(3):282-8. https://doi.org/10.5551/jat.20628.

43. Mario FM, Graff SK, Spritzer PM. Adiposity Indexes as PhenotypeSpecific Markers of Preclinical Metabolic Alterations and Cardiovascular Risk in Polycystic Ovary Syndrome: A CrossSectional Study. Exp Clin Endocrinol Diabetes. 2017;125(5):307-15. https://doi.org/10.1055/s-0042-119524.

44. de Oliveira C, Roriz A, Ramos LB, et al. Indicators of Adiposity Predictors of Metabolic Syndrome in the Elderly. Ann Nutr Metab. 2017;70(1):9-15. https://doi.org/10.1159/000455333.

45. Vieira BA, Sauer P, Marcadenti A, et al. Association between LAP index (lipid accumulation product) and metabolic profile in hospitalized patients. Nutr Hosp. 2015;31(6):2771-4. https://doi.org/10.3305/nh.2015.31.6.8957.

46. Wakabayashi I. Associations of blood lipid-related indices with blood pressure and pulse pressure in middle-aged men. Metab Syndr Relat Disord. 2015;13(1):22-8. https://doi.org/10.1089/met.2014.0093.

47. Rotter I, Ryl A, Szylinska A, et al. Lipid Accumulation Product (LAP) as an Index of Metabolic and Hormonal Disorders in Aging Men. Exp Clin Endocrinol Diabetes. 2017;125(3):176-82. https://doi.org/10.1055/s-0042-116071.

48. Er LK, Wu S, Chou HH, et al. Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals. PLoS One. 2016;11(3):e0149731. https://doi.org/10.1371/journal.pone.0149731.

49. Wanderley Rocha DR, Jorge AR, Braulio VB, et al. Visceral adiposity measurements, metabolic and inflammatory profile in obese patients with and without type 2 diabetes mellitus: a crosssectional analysis. Curr Diabetes Rev. 2017;13(1):11-8. https://doi.org/10.2174/1573399812666151015115924.

50. Lwow F, Jedrzejuk D, Milewicz AL, Szmigiero L. Lipid accumulation product (LAP) as a criterion for the identification of the healthy obesity phenotype in postmenopausal women. Gerontol. 2016;82:81-7. https://doi.org/10.1016/j.exger.2016.06.007.

51. Шляхто Е. В., Недогода С. В., Конради А. О. и др. Концепция новых национальных клинических рекомендаций по ожирению. Российский кардиологический журнал. 2016;(4):7-13. https://doi.org/10.15829/1560-4071-2016-4-7-13.